Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand
First FDA-Cleared Antibiotic-Eluting BioEnvelope Now Available in U.S. for Implantable Pacemakers, Defibrillators, and Neurostimulators SILVER SPRING, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ...
Active Implantable Medical Devices Market Expected To Reach USD 33.76 Billion By 2032 With ...
Future wound care: regenerative medicine, smart dressings, nanotech.United Kingdom, London, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Introspective ...